Therapeutic Area: Otolaryngology (Ear, Nose, Throat) Product Name: Momat Rino Advance
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Dr. Reddy\'s Laboratories
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Divestment November 28, 2020
The divested brand and its extensions represent two types of products, (a) Mometasone mono product and (b) combination of Mometasone with Azelastine, and are indicated for the treatment of Seasonal and Perennial Allergic Rhinitis.